Furthermore, significantly elevated serum VEGF levels have been identified in patients with metabolic syndrome [43], suggesting that a systemic metabolic factor might induce VEGF, which is associated with a higher HS and increased likelihood of AE-IIPs. The gene discussed is VEGFA; the disease is metabolic syndrome.